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Abstract.  By pulse-chase labeling with [35S]methio- 
nine and long-term labeling with 3H-sugars, the E1 
glycoprotein of coronavirus MHV-A59 has been shown 
to acquire O-linked oligosaccharides in a two-step pro- 
cess.  About 10 min after synthesis of the E1  protein, 
N-acetyl-galactosamine was added. This was followed 
~10 min later by the addition of both galactose and 
sialic acid to give the mature oligosaccharides. This 
sequence of additions was confirmed by analyzing the 
3H-labeled oligosaccharides bound to each of the El 
forms using gel filtration on P4 columns. The intracel- 
lular location of the first step was determined by ex- 
ploiting the temperature sensitivity of virus release. 
The virus normally buds first into a  smooth membrane 
compartment lying between the rough endoplasmic re- 
ticulum and the cis side of the Golgi stack (Tooze et 
al.,  1984).  At 31°C  the virus is assembled but does 
not appear to enter the Golgi stacks.  The addition of 
N-acetyl-galactosamine is unaffected although the addi- 
tion of galactose and sialic acid is inhibited. These 
results strongly suggest that addition of N-acetyl-galac- 
tosamine occurs in this budding compartment, the 
morphology of which is similar to that of transitional 
elements and vesicles. 
p 
ROTEINS exported  from  the  endoplasmic  reticulum 
(ER)'  move  through  each  of the  cisternae  of the 
Golgi stack before they are directed to their correct 
destination either inside or outside the cell (Rothman, 1981; 
Griffiths and Simons,  1986; Pfeffer and Rothman,  1987). 
Many proteins undergo a  series of posttranslational modi- 
fications during this transport including the addition of  oligo- 
saccharides  which  are  either  N-linked  to  asparagine  or 
O-linked to serine or threonine. The sequence of modifica- 
tions to these covalently bound oligosaccharides reflects the 
movement of the protein from one compartment to the next 
on the transport pathway. The addition and modification of 
the N-linked oligosaccharides has been extensively inves- 
tigated (reviewed by Kornfeld and Kornfeld, 1980) but much 
less is known about the addition of O-linked oligosaccha- 
rides. For the simplest and most common type there is in- 
direct evidence that construction of the O-linked glycans is 
a two-step process, the addition of N-acetyl-galactosamine 
(GalNAc) preceding that of galactose (Gal) and sialic acid 
(NANA). The addition of the last two sugars almost certainly 
occurs in the trans part of the Golgi stack (Cummings et al., 
1983; Elhammer and Kornfeld, 1984). Proposals for the site 
of addition of the first sugar, however, range from the rough 
ER (Strous, 1979), where the proteins are assembled, to the 
1. Abbreviations used in this paper: ER, endoplasmic reticulum; Gal, galac- 
tose; GalNAc, N-acetyl-galactosamine; MEM-met, methionine-free modi- 
fied Eagle's medium; MHV-A59, mouse hepatitis virus, strain A59; NANA, 
N-acetyl-neuraminic acid (sialic acid); Tx-114, Triton X-tI4. 
cis part of the Golgi stack which is the entry point for pro- 
teins that have left the ER (Cummings et al.,  1983; Roth, 
1984), to the medial part (Niemann et al., 1982; Elhammer 
and Kornfeld, 1984), and finally to the trans-Golgi cisternae 
(Johnson and Spear,  1983). Most of the evidence supports 
the idea that GalNAc is added either just before or just after 
the protein leaves the ER. There are several reasons why it 
has proven so difficult to locate the site of this first sugar ad- 
dition, of which the absence of a combined biochemical and 
morphological study of the O-glycosylation of a single pro- 
tein must rank as the most important. 
The E1 envelope protein of  coronavirus MHV-A59 (Mouse 
Hepatitis Virus, strain A59) contains only O-linked oligosac- 
charides and is, therefore, a good model for studying addi- 
tion of O-linked sugars. MHV-A59 buds intracellularly and 
E1  is the only viral membrane protein needed for budding 
(Holmes et al., 1981a, b; Rottier et al., 1981). After synthesis 
in the rough ER this protein is transported to a smooth mem- 
brane compartment between the rough ER and Golgi stack 
where it accumulates allowing nucleocapsids in the cyto- 
plasm to bind which results  in the  formation of a  virion 
(Holmes et al., 1981a; Tooze et al., 1984). The virions then 
follow the secretory pathway out of the cell (Holmes et al., 
1981b; Tooze et al.,  1987). The virions contain in addition 
to E1 a second envelope glycoprotein, E2, which is essential 
for infectivity (Sturman,  1981) and is incorporated at some 
as yet undefined stage during the budding or transport of the 
virions through intracellular compartments. E2 is a fusogen 
and is also transported in cellular membranes to the plasma 
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the fusion of infected cells with contiguous uninfected cells 
(Sturman and Holmes,  1983). 
Reduced temperature has proven to be a very useful tool 
in analyzing compartments on the exocytic transport path- 
way. Different steps  are differentially sensitive so that pro- 
teins accumulate at different stages. This has led to the mor- 
phological characterization of a compartment similar to the 
coronavirus budding compartment, but found in baby ham- 
ster kidney (BHK) cells infected with Semliki Forest virus 
and incubated at 15°C (Saraste and Kuismanen, 1984). Here 
we  exploit  reduced  temperature  to  prevent  movement of 
coronavirus and analyze the oligosaccharides bound to E1 on 
the arrested virus. We also present evidence showing that the 
budding compartment, which by morphological criteria is 
clearly related to transitional elements and transitional vesi- 
cles, as classically defined in exocrine pancreatic cells by the 
work  of Palade  and  colleagues  (Caro  and  Palade,  1964; 
Jamieson and Palade, 1967), is not created by the process of 
infection but exists in the uninfected cell. A  physiological 
function of this compartment appears to be the addition of 
GalNAc, implying that it contains the enzyme which adds 
this sugar to serine and threonine residues. 
Materials and Methods 
Materials 
All cell culture reagents were supplied by BRL-Gibco, Karlsruhe, Federal 
Republic of Germany (FRG) and all cell culture plasticware by Falcon Lab- 
ware, Becton, Dickinson & Co., Heidelberg, FRG. Monensin was a gift of 
Eli Lily & Co., Indianapolis, IN. CCCP (carbonyl cyanide m-chlorophenyl 
hydrazone), Pronase (sp act 70,000 proteolytic units/g), and Pansorbin were 
supplied by Calbiochem-Behring Corp., Frankfurt, FRG. [l,6-3H]Glucosa  - 
mine (sp act 30 mCi/mmol), [methylJ4C]BSA (sp act 17~tCi/mg, I6-3H] - 
N-acetyl-marmosamine (sp act 30 mCi/mmol), and EN3HANCE were sup- 
plied by New England Nuclear, Boston, MA. Na[3H]B4 (sp act 14.4 Ci/ 
mmol),  D-llJ4C]mannose (sp act 49.4  mCi/mmol),  UDP-N-acetyl-o-[1- 
~4C]galactosamine  (sp act 45-55  mCi/mmol),  D-[U-~4C]galactose  (sp act 
57  mCi/mmol),  I>[l-~Hlgalactose  (sp  act  10.4 mCi/mmol),  N-acetyl 
[4,5,6,7,8,9-14C]neuramic  acid  (NANA)  (sp  act  244  mCi/mmol),  and 
[35S]methionine  (sp  act  1,100-1,300  mCi/mmol)  were  obtained  from 
Amersham Buchler GmBH, Braunschweig, FRG. Test neuraminidase from 
Vibrio cholera was obtained from the Behring Institute, Frankfurt, FRG. 
Neuraminidase (type V)  isolated from Clostridium perfringens  was ob- 
tained from Sigma, Chemical GmbH, Munich, FRG. Amberlite mixed bed 
resin MB-1  was purchased from BDH Chemicals, Ltd., Poole, England. 
Moviol was purchased from Thomas Scientific, Philadelphia, PA. All other 
solid chemicals and reagents were obtained from Sigma Chemical GmbH, 
Munich, FRG. Liquid reagents were obtained from E. Merck, Darmstadt, 
FRG. 
Cells and Virus 
MHV-A59 was propagated on sac(-) cells (Tooze et al.,  1984) and titered 
by plaque titration on confluent monolayers of L cells as follows.  After in- 
fection for 1 h at 37°C, the monolayers were overlaid with 2% carboxy- 
methyl cellulose and incubated for 24 h at 37°C in 95% air/5% COs incu- 
bator.  The monolayers were then fixed and stained with 35  mM Tris-Cl 
buffer,  pH 7.2,  containing 0.25%  (wt/vol) crystal violet,  1.75% (vol/vol) 
formaldehyde, 10% (vol/vol) MeOH, and 0.5% (wt/vol) CaCI2 (K~ari~inen 
et al.,  1969). 
Indirect Immunofluorescence 
Sac(-) cells grown on coverslips and infected with MHV-A59 were fixed 
with 3% formaldehyde and labeled (Tooze et al., 1984) using either a mAb 
directed against E1 (4-17-M1-F4-M1; gift of M. Koolen, Utrecht, and A. Os- 
terhus, National Institute of Public Health, Bilthoven, Holland) or an anti- 
body directed against an endogenous Golgi protein (Burke et al., 1982). The 
second antibody (rabbit anti-mouse), kindly provided by Dr.  B.  Burke, 
European Molecular Biology Laboratory,  Heidelberg, FRG,  was affinity 
purified and conjugated to rhodamine. The fixed and labeled coverslips were 
mounted in Moviol and viewed by epifluorescence on a Zeiss photomicro- 
scope III. 
Electron Microscopy 
Infected sac(-) cells in 35-mm dishes were fixed, dehydrated, and embed- 
ded in Epon as previously detailed (Tooze et al.,  1984). 
Immunoperoxidase Labeling 
The anti-E1  antibody (4-17-M1-F4-M1) was used  for immunoperoxidase 
labeling after our standard protocol (Tooze et al.,  1984). 
FsS]Methionine Labeling of MHV-A59 and 
the E1 Glycoprotein 
Infected sac(-) cells, in 35-mm dishes, were either pulse labeled or con- 
tinously  labeled  with  [35S]methionine.  After  washing  three  times  in 
methionine-free modified Eagle's medium (MEM-met), cells were labeled 
with  100-250  ~tCi [35S]methionine  for 5-10  min at  37°C,  or  for longer 
periods at 35, 31, 30, 25, and 20°C. Some cells were chased at 37 or 31°C 
for various times by the addition of growth medium containing 1.5 mg/ml 
of methionine, 10×  the normal amount. For quantitation of the number of 
El molecules labeled [35S]methionine  with a defined specific activity was 
used. The cells were'washed  with ice cold PBS and extracted with 1% Triton 
X-114 (Tx-ll4) in PBS containing 40 ~tg/ml phenylmethylsulfonyl fluoride 
(PMSF) at 4°C.  The insoluble residue was removed by centrifugation at 
10,000 g~ for 5 min at 4°C. The detergent phase, enriched in the El glyco- 
protein, was isolated from the detergent-soluble extract as described by Bor- 
dier  (1981). The  medium containing labeled virions was  collected and 
layered onto a 20-50% continuous sucrose gradient as described by Spaan 
et al. (1981). The virions were harvested from the gradients after centrifuga- 
tion for 3 h at 100,000 ga~. The El glycoprotein was extracted from virions 
using Tx-ll4 as detailed above. The El-enriched detergent extracts from cells 
or virus were solubilized and reduced in sample buffer,  alkylated (Green 
et al.,  1981), and then fractionated by SDS-PAGE using a  15%  running 
gel and a  5%  stacking gel  (Maizel,  1971). Incorporation of radioactive 
[35S]methionine was determined after TCA precipitation (Mans and Novel- 
li, 1961) and equal counts were loaded onto each lane unless otherwise indi- 
cated. Gels were fixed using 10% (wt/vol) TCA,  treated with EN3HANCE, 
dried, and exposed to Kodak XS film for 1-5 d at  -80°C. 
To quantitate the [3~S]methionine  incorporated in the E1  glycoprotein 
the fluorogram was exposed to Kodak X-AR5 film. The fluorograph was 
then used to locate the E1 bands in the fluorogram. The excised pieces were 
rehydrated and incubated in 0.5  ml of 30% (vol/vol) H202 in  10 mM HC1 
at 60°C for 48 h. Scintillation fluid (10 ml) (Rotizant 22, Firma Roth, Karls- 
ruhe,  FRG)  was then added and  the samples were cooled to  4°C  and 
counted. Gel pieces of equivalent sizes from areas containing no samples 
were treated similarly and used to provide blanks which were typically <1% 
of the experimental values. 
Immunoprecipitation and Neuraminidase Digestion 
of the E1 Glycoprotein 
[35S]methionine-labeled  cells were solubilized in RIPA buffer (10 mM Tris- 
HCI, pH 7.6, 0.15 M NaCI,  1% [wt/vol] Triton X-100, 0.1% [wt/vol] SDS, 
and 1% [wt/vol] sodium deoxycholate) containing a cocktail of protease in- 
hibitors (40 ~tg/ml PMSF, 1 lag/ml leupeptin, 1 Ixg/ml antipain, 1 mM ben- 
zamidine, and 10 U/ml Trasylol). The extract was centrifuged at 10,000 ga~ 
and the supernatant was treated with 5 111 of a polyclonal antiserum raised 
against a Triton X-114 extract of gradient-purified virions (Tooze and Stanley, 
1986). After overnight incubation at 4°C, the immune complexes were im- 
mobilized on Pansorbin for 1 h at 37°C and washed three times with RIPA 
buffer. 
One half of the sample was then digested with 1 mU/ml neuraminidase 
from Clostridium perfringens in 10 mM sodium acetate buffer, pH 5.6, con- 
mining 1 mM CaC12, for 16 h at 37°C. The digested immune complexes 
were then washed well with 10 mM Tris-HCl buffer, pH 7.2, containing the 
protease inhibitor cocktail. These samples, together with the untreated ones, 
were then prepared for and fractionated by SDS-PAGE. 
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Units at 31 ° C 
Hours after infection 
6-8 h  6-12 h 
37°C *  1.0  x  105  7.3  x  107 
31°C *  nd~  8.1  ×  10  -~ 
Inhibition  >1  x  105-fold  900-fold 
at 31°C 
The growth medium was changed at 6 h after infection and cultures were either 
left at 37°C or shifted to 31 °C for the time period indicated.  The cultures were 
treated  at 3.5 h after infection  with proteinase K to remove any virions from 
the infecting stock bound to the surface. 
* Temperature of incubation. 
nd, none detectable  in undiluted supernatant. 
Preparation of  E1 Glycopeptides 
Infected sac(-) cells (2  ×  108 cells) were labeled for 12 h with 25 laCi/ml 
[1,6-3H]glucosamine in MEM containing 10% the normal concentration of 
glucose (100 I.tg/ml),  10% (vol/vol) dialyzed FCS, 10 mM Hepes buffer, pH 
Z2,  10 mM sodium pyruvate, and 100 Ixg/ml each of penicillin and strep- 
tomycin. The cells were solubilized in RIPA buffer and the El glycoprotein 
was immunoprecipitated as described above. The procedures described be- 
low  are adapted from Cummings et al.  (1983).  After SDS-PAGE the in- 
dividual glycosylated forms of E1  were  excised from the dried gel,  re- 
hydrated, and digested with pronase (final concentration 5  mg/ml). The 
glycopeptides were eluted from the gel pieces using HzO. The eluate con- 
mining the glycopeptides was then lyophilized and resuspended in H20. 
Preparation of  E10ligosaccharides by Mild 
Alkaline Hydrolysis 
Glycopeptides were acetylated by treatment with acetic anhydride (Baen- 
ziger and Kornfeld, 1974) and desalted over an Amberlite mixed bed resin 
before mild alkaline hydrolysis. The eluate,  after lyophilization,  was re- 
suspended in 0.2 M  sodium carbonate, pH 11.6, then treated with an equal 
volume of 2 M  NaBH4 in 100 mM NaOH, and incubated for 16 h at 45°C 
as described by Niemann and Klenk (1981). After neutralization at 4°C with 
glacial  acetic  acid,  the  oligosaccharides  were  passed  over  a  Dowex 
50W-X8H  + column and eluted  with  1%  (vol/vol)  acetic  acid.  The peak 
fractions containing the oligosaccbarides were pooled and lyophilized. The 
borate was removed by repeated evaporation with methanol at 40°C. The 
oligosaccharides were  finally resuspended in 200  ~t distilled  H20.  The 
final recovery of [3H]-Iabeled  material was 80-90 %. One-half of the mate- 
rial was applied directly to a P4 (200-400 mesh) column (90  ×  1.5 cm), 
equilibrated, and run in 0A M  NaHCO3, pH 8.6. The remainder was first 
digested with neuraminidase from Vibrio cholerae at a final concentration 
of I U/ml in 50 mM sodium acetate buffer, pH 5.6, containing 154 mM NaCI 
and 9 mM CaC1,. After incubation under a toluene atmosphere for 24 h at 
37°C (Niemann and Klenk, 1981), the reaction was stopped by boiling, and 
the samples were lyophilized and then resuspended in  100 I.tl of distilled 
H.,O before application to the P4 column. 
Preparation of  P4 Column Standards 
[3H]Glucose3mannose~/-acetylglucosamine was  prepared  from  Chinese 
hamster ovary (CHO) (clone  15B cells) infected with vesicular stomatitis 
virus as described by Featherstone et al.  (1985).  The glycopeptides were 
prepared  and the dolicol-linked oligosaccharide in the Tx-ll4 pellet  was 
released by endoglycosidase H digestion. [3HlGall3(l--3)-GalNAcitol was 
prepared by reduction of Gall3(1-'3)-GalNAc (generously supplied by Dr. 
W.  Gielen, University of Cologne, FRG),  with NaB3H4 (Li et al.,  1978). 
[t4C]GalNAcitol  was prepared  by  acid hydrolysis of UDP-N-acetyl-D-[1- 
t4C]galactosamine (Cummings et  al.,  1983),  followed by  reduction with 
NaBH4 (Li et al.,  1978). [14C]Galacitol  was prepared from o-[U-~4C]galac  - 
tose by mild alkaline hydrolysis as described above. The remaining stan- 
dards [~4C]BSA, [~4CINANA,  and [~4C]mannose were used directly as pur- 
chased. 
Results 
Virus Release Is Blocked at Reduced Temperature 
but EI Synthesis Continues 
At 37°C,  sac(-) cells release progeny virus exponentially, 
beginning at ~5 h after the start of infection and continuing 
until the cells lyse. The release of E1  molecules in virions 
parallels the  release of virus particles  consistent with the 
known dependence of budding on the E1 glycoprotein (Tooze, 
1987). Holmes and Behnke (1981) observed in a preliminary 
morphological study that at 32°C  virions were assembled, 
but  accumulated  within  the  infected cell  instead  of being 
released. To confirm this observation, infected sac(-) cells 
were incubated for 6 h at 37°C and the release of infectious 
virus was measured by a plaque titration assay over the next 
6 h in cultures either kept at 37°C or shifted to 31°C.  As an 
added precaution, cells were treated for 2-3 min with pro- 
teinase K 3.5 h after infection to remove any virions from the 
infecting inoculum still remaining on the cell surface. This 
ensured that only released progeny particles were measured. 
Table I  summarizes the  results  from two  separate experi- 
ments and shows that the 6°C drop in incubation temperature 
caused at least a  1,000-fold  drop in the release of infectious 
virus. 
Virions  lacking  E2  are  not  infectious  (Holmes  et  al., 
Table II. Effect of  a Decrease to 31 ° C on the Distribution of  E1 
Experiment 1  Experiment 2 
Temp  cpm*  % 31/37°C  Temp  cpm*  % 31/37°C 
Virion-  37°C  6.1  x  104  37°C  0.6  x  103 
associated E1  18.1  16.7 
31°C  1.1  ×  104  31°C  0.1  x  103 
Total  El  37°C  6.7  ×  105  37°C  1.3  x  104 
(intracellular and  73.1  84.6 
virion associated)  31°C  4.9  x  10  -~  31°C  1.1  x  104 
Infected  cells were labeled  from 6 to 9 h after infection  with [3~S]methionine in MEM-met containing 5 Ixg/p.I cold methionine at 37 or 31 °C. At the end of the 
labeling period the cells were treated  with 0.5 mg/ml proteinase K at 4°C for 2-3 min. The proteinase K was neutralized with PMSF and the cells were pelleted 
at 4°C. The supernatant was then pooled with the medium collected  from the cells before the proteinase K treatment and the labeled  virions were purified  on 
sucrose gradients. Both cells and virions were subjected to Tx-114 extraction followed  by SDS-PAGE. 
* Counts per minute in all forms of El detected by fluorography, including the lower molecular weight forms of El  generated by proteinase K digestion (Rottier 
et al.,  1984). 
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that at 31°C the cells were releasing large numbers of nonin- 
fectious particles,  which  would  not be scored in an infec- 
tivity assay, El contained in virus particles released from the 
cells was quantitated.  Infected cells were labeled from 6 to 
9 h after infection with pSS]methionine at 37 and 31°C, the 
medium was collected,  and any labeled virions associated 
with the plasma membrane were removed by proteinase K 
treatment at 4°C and pooled with the virions in the medium. 
After SDS-PAGE and fluorography of virions purified from 
the medium, the E1 band was excised and counted. As shown 
in Table II, the 6°C drop in temperature during the labeling 
period  inhibited  the  release  of  virion-associated  E1  by 
>80%. In marked contrast, however, the total amount of E1 
synthesized was reduced  by only ,x,20%  upon shifting the 
temperature to  31°C  (Table II). Total protein  synthesis,  in 
both infected and uninfected cells, was on average decreased 
by only 23 % over the same time period. 
The discrepancy between the observed 1,000-fold decrease 
in the release of infectious virions (Table I) and the fivefold 
decrease in the release of virion-associated E1 (Table II) may 
mean that at 31°C more noninfectious particles are assem- 
bled and released. However, we favor an alternative explana- 
tion,  namely,  that  proteinase  K  treatment  damages  some 
cells and leads to artifactual release of intracellular virions 
because, when medium is collected from cells at 31°C with- 
out  proteinase  K  treatment,  the  amount  of  methionine- 
labeled virion-associated E1 is below the limits of detection 
by fluorography after SDS-PAGE (data not shown). Further- 
more,  electron microscopic studies  of thin  sections of in- 
fected cells incubated at 31°C from 7 to 24 h after infection 
reveal  very  few  extracellular  virions  associated  with  the 
plasma membrane (see below and Fig.  10). 
These data show that E1  synthesis continues almost nor- 
mally at 31°C but the release into the medium of virions is 
dramatically inhibited. To determine the site of accumulation 
of virions and E1 at 31°C a combination of both biochemical 
and morphological techniques  was used. 
Glycosylation of  E1 Is a Two-step Process 
At 37°C and 8 h after infection, sac(-) cells were pulsed for 
5 min with [35S]methionine  and then chased in the presence 
of excess unlabeled  methionine  for up  to 40  min.  Fig.  1 
shows  that  a  proportion  of the  unglycosylated E1  protein 
(E/u, lane 1 ) is converted after 10 min of chase to an inter- 
mediate form of higher molecular weight (E/i,  lane 2) and 
Figure  I.  Glycosylation  of 
El.  Sac(-) cells at 8 h after 
infection  were  pulse  labeled 
(lane 1 ) for 5 min or pulse la- 
beled and chased (lane 2) for 
10 min, (lane 3) 20 min, and 
(lane  4)  40  min.  Equal  vol- 
umes  of the  detergent  pellet 
from a Tx-114 extract of the 
cells  were  loaded  on  each 
lane. The unglycosylated form (El,) is modified ,~ l0 min after a 
5-min pulse to the  intermediate  form (Eli). Subsequently,  after 
20 min of chase the mature forms appear (Elm). 
Figure 2. Metabolic labeling of El with 
3H-sugars. Infected  sac(-) cells  were 
labeled  from  7  to  8.5  h  after  infec- 
tion  with  either  (lane  1)  0.2  gCi/gl 
PSlmethionine,  0.25  gCi/gl  (lane  2) 
[3H]glucosamine (Glc), (lane  3)  [3H]- 
galactose  (Gal), or  (lane  4)  [3H]-N- 
acetylmannosamine  (NAMA). The  ceils  were  extracted  with 
Tx-114/PMSF  and subjected to SDS-PAGE.  Equal volumes were 
loaded  onto  each  lane  which  contained  (lane  1)  124,000 cpm; 
(lane 2) 4,100 cpm;  (lane 3) 4,300 cpm; and (lane 4) 650 cpm. 
To detect the radioactive  label, the fluorograph was exposed for 
(lane 1) 3 d; (lanes 2 and 3) 3 wk; and (lane 4)  1 yr. Dot indi- 
cates the El, band labeled with [3H]glucosamine. 
after ",,20 min of chase (lane 3) to the mature forms (E/m), 
which in this experiment consisted of three distinct polypep- 
tides differing in molecular mass by ~4 kD. Three forms of 
E1 were always detected (Fig. 1, lane 4), and in some experi- 
ments varying but small amounts of two additional higher 
molecular  mass  forms  were  resolved.  The  observed  in- 
creases in  molecular mass must be due to the addition of 
O-linked oligosaccharides (Holmes et al.,  1981a; Niemann 
and  Klenk,  1981; Rottier  et  al.,  1981), which  is  the  only 
known posttranslational modification of El.  The intermedi- 
ate form EI~ has not, however, been previously detected and 
the heterogeneity of mature forms resolved in Fig.  1 was not 
seen in previous work with the same virus propagated in a 
different cell line (e.g.,  Niemann et al.,  1982). 
To determine the  sugar composition of the oligosaccha- 
rides bound to each of the E1 forms, infected cells were la- 
beled from 7 to 8.5  h after infection with 3H-precursors of 
each of the  sugars expected to be present in  the  O-linked 
oligosaccharides,  extracted  with  Tx-ll4,  and  subjected  to 
SDS-PAGE followed by fluorography. As expected, Elu, the 
unglycosylated form of El,  was not  labeled by any of the 
3H-sugars (Fig. 2, cf. lane 1 with lanes 2-4). [3H]Galactose 
and [3H]N-acetyl-mannosamine are specific metabolic pre- 
cursors  of Gal and  NANA,  respectively (Neutra  and  Le- 
blond,  1966;  Monaco and Robbins,  1973), and these were 
found to label only the Elm  forms (Fig.  2,  cf.  lane 1  with 
lanes  3  and  4).  The  presence of NANA  in  Elm was also 
confirmed by treatment of [35S]methionine-labeled E1  with 
neuraminidase.  The  Elm polypeptides alone were reduced 
in molecular mass to a form which migrated slightly slower 
than EI~ (Fig. 3, lane 4) and was assumed to have O-linked 
oligosaccharides composed of Gal-GalNAc. Mature forms 
of E1 are known to contain two types of O-linked oligosac- 
charides:  (a)  a  disialylated  form (Niemann  et  al.,  1984), 
NANAct(2----3)Gall3(1---3)(NANAct[2~6])GalNAc; and (b) 
a  monosialylated form, NANAa(2--'3)GalI~(I"-'3)GalNAc. 
The intermediate form of E1 (Eli) was labeled by [3H]glu- 
cosamine (Fig.  2,  lane 2)  which  is converted by cells into 
[3H]GalNAc,  [3H]NANA,  and  [3H]GIcNAc.  Eli  does not, 
however, contain NANA because it was not labeled by [3H]- 
N-acetyl-mannosamine (Fig. 2, lane 4). EI~ was also not la- 
beled  by  [3H]Gal  (Fig.  2,  lane  3).  Based  on  the  known 
structure  of the  oligosaccharides,  these  data  indicate  that 
GalNAc  is  most likely  the  only  sugar  present  in  the  EI~ 
form. 
The Journal of Cell Biology, Volume 106, 1988  1478 Figure 3.  Neuraminidase  digestion  of El.  Infected  sac(-) cells 
were pulse labeled for 10 min with 0.2 IsCi/~l [3sS]methionine or 
pulse labeled and chased for 60 min at 37°C. After immunopre- 
cipitation, the samples were divided in half and were either (lanes 
1 and 2) incubated without neuraminidase  in the digestion buffer 
or (lanes 3 and 4) with 0.2 mU/ml neuraminidase in the digestion 
buffer at 37°C overnight.  Equal volumes were loaded onto each 
lane.  *,  the major digestion  product  after neuraminidase  treat- 
ment. 
The Intermediate Form of  E1 Contains GalNAc 
To confirm that the intermediate form of E1 results from the 
addition of GalNAc, infected cells were labeled from 4 to 16 
h  after infection with  [3H]glucosamine at 37°C.  The virus 
was purified from the medium,  solubilized in Tx-114, and 
pooled with the labeled cells that were also solubilized in Tx- 
114. After phase extraction, E1 was immunoprecipitated and 
resolved by SDS-PAGE followed by fluorography. The poly- 
peptides were excised from the gel in two groups, the lower 
(Elu and Eli) and higher (Elm) molecular mass forms, and 
analyzed by P4 column chromatography after alkaline hy- 
drolysis  to  release  the  oligosaccharide  side  chains.  Any 
oligosaccharides  released from the  lower molecular mass 
forms of E1 must have originated from Eli since Elu is not 
labeled by [3H]glucosamine (Fig.  2,  lane 2).  As shown in 
Figure 4 a, a single peak of 3H-sugar ran at the position of 
GalNAcitol (the alcohol derivative of GalNAc), which was 
not sensitive to treatment with neuraminidase (Fig. 4 b). The 
two  predominant  3H-labeled  oligosaccharides  from  Elm, 
(peaks Fig. 4  c, A and B) correspond to the dis!alyated and 
monosialylated oligosaccharides. After treatment with neu- 
raminidase,  both A  and  B  are  converted quantitatively  to 
NANA (Fig. 4 d, peak C) and Gall3(1--'3)GalNAcitol (Fig. 
4  d, peak D).  These sugars, as well as GalNAcitol (Fig. 4 
d, peak E), are present in the untreated samples (Fig. 4 c), 
most likely as degradation products of alkaline hydrolysis. 
Taken together, the experiments described so far show that 
GalNAc is the first sugar added to the E1 protein, followed 
at a  later time by Gal and NANA. 
Reduced Temperature Blocks Conversion of  E1 
to the Mature Form 
To  examine  the  effect  of  decreased  temperature  on  the 
glycosylation of El, infected cultures were labeled for 143 rain 
at 37°C and then chased at either 37 or 31°C (Fig. 5). After 
90 rain of chase at 37°C, all forms of E1 were detectable in 
cell extracts (Fig. 5, lane 2).  After 180 rain there was a de- 
crease in the amount of all forms of labeled E1 (Fig. 5, lane 
3), presumably because the labeled E1 molecules had been 
incorporated into virions which were then transported out of 
the cell. When the cultures were shifted to 31°C for the chase 
period, the glycosylation of E1 was blocked in the intermedi- 
ate form (Fig. 5, lanes 4 and 5). This block was maintained 
after 180 min of chase, with no detectable decrease in either 
the unglycosylated or the intermediate form (Fig. 5, compare 
lanes 2 and 4 with lanes 3 and 5). If, after 90 min of chase 
at 31°C, the infected cultures were returned to 37°C for a fur- 
ther  90  min,  the  amounts  of the  Elu  and  Eli  forms de- 
creased (Fig.  5,  lane 6) concomitant with release of virus. 
Reduced Temperature Does Not Change the 
Amount of  the Intermediate Form of  El 
Cells infected for 7 h at 37°C were incubated for 3 h at vari- 
ous lower temperatures in the presence of [35S]methionine. 
The total amount of E1  present both intracellularly and in 
virions adhering to the surface was then determined after the 
extract  was  subjected  to  SDS-PAGE.  The  three  different 
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Figure 4. P4 column chromatography  of the oligosaccharides  iso- 
lated  from the  unglycosylated  form (Elu)  and  the intermediate 
form (Eli) (a and b), and the mature form (Elm) of E1 (c and d). 
The oligosaccharides  were chromatographed  either  (a and c) be- 
fore neuraminidase  digestion,  or (b and d) after neuraminidase 
digestion.  In a  the  oligosaccharides  released  from the  Elu and 
EL bands  elute  as  a  single  major peak (E)  with  a K,v  --- 0.8, 
which (b) is not affected by neuraminidase digestion. In c the two 
mature forms of E1 (peaks A and B) are released from Elm and, 
in addition,  three other peaks (C, D, and E) with a Kay of 0.41, 
0.77, and 0.85,  respectively,  were detected.  (d) After neuramini- 
dase digestion of the oligosaccharides released from the Elm form, 
the counts contained in peaks A and B were quantitatively recov- 
ered in peaks C and D. The numbers at the top correspond  to the 
standards  (1)  [14C]BSA; (2)  [3H]GIc3MangGlcNAc; (3)  [14C]- 
NANA;  (4)  [3H]Gall31~3-GalNAcitol;  (5)  [3H]GalNacitol; (6) 
[t4C]Galacitol; and (7) [=4C]mannose. 
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Figure 5.  Reversibility  of the 31°C block. Infected sac(-) cells  ~100i 
were pulse labeled  for 10 min with 0.2 gtCi/I.tl of [35S]methionine  .~ 
at 37°C (lane  1) or pulse labeled  and chased at 37°C for either  ~ a0 
90 (lane 2) or 180 rain (lane 3). Alternatively,  after the pulse label 
at 37°C, the cultures were chased at 31°C for 90 (lane 4),  180 (lane  ~  60 
5), or 90 min (lane 6) at 31°C, and then chased an additional  90  ~, 
min  at  37°C.  The  inhibition  of processing of El0  is  detectable  ~  6o 
(compare lanes 2 and 4 with lanes 3 and 5) over 180 min,  and is 
reversible after 90 min (compare lanes 1 and 2 with lanes 4 and 6).  .~  2o 
forms of El  were excised from the gel and quantitated;  the 
results are presented  in Fig.  6  a.  As expected from Fig.  5, 
a  decrease  in the  incubation temperature  reduces the  per- 
centage of E1  m  and increases the percentage of E1 o. Surpris- 
ingly, the percentage of EI~ remains approximately constant 
at all the temperatures.  In a separate experiment the absolute 
amounts of each of the E1  forms were measured at both 37 
and 31°C and, as shown in Fig. 6 b, the decrease in the ma- 
ture forms, Elm, was accompanied by an increase in the un- 
glycosylated  form,  Elo,  but  there  was  no  change  in  the 
amount of the intermediate  form,  EI~. 
Perinuclear Localization of  E1 at 37 and 31°C 
To relate the block in oligosaccharide maturation to the intra- 
cellular localization of El, infected cells were labeled for in- 
direct immunofluorescence microscopy, using a mAb against 
El.  At 7  h  after  infection  at  37°C,  E1  was  restricted  to a 
perinuclear region (Fig. 7 a) and the pattern of labeling was 
similar to, but more extensive than, that observed with anti- 
bodies  specific  for an  endogenous  Golgi protein  (data  not 
shown). Between 7 and 12 h after infection at 37°C syncytia 
developed, each containing several hundred nuclei, and con- 
comitantly E1 became detectable in the rough ER throughout 
the cytoplasm (Fig. 7 b). At these late times the mAb against 
E1  also labeled  patches  at the cell  surface  (Fig.  7  b);  this 
labeling we attribute to released progeny virions, which are 
known  to  remain  closely  associated  with  the  cell  surface 
(Dubois-Dalcq et al.,  1984). 
In contrast, when the cells were shifted at 7 h after infec- 
tion to 31°C and incubated until  12 h after infection, the E1 
labeling within the cells remained restricted to the peri-Golgi 
region, although the area and intensity of labeling increased 
above that seen at 7 h after infection (Fig. 7, a  and c).  Fur- 
thermore,  neither the rough ER nor the surface of cells in- 
cubated  from 7  to  12  h  after  infection  at  31°C  labeled  for 
El.  These  observations  imply  that  E1  accumulated  in  the 
perinuclear  region during  the  incubation  at  31°C  and  that 
virions were not transported out of the cell.  During the 5-h 
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a  Figure 6.  Quantitation  of the 
intermediate  form, El~. Infec- 
ted sac(-) cells  were labeled 
continuously at  the  indicated 
temperature  with [35S]methio- 
nine  in MEM-met containing 
2.5  ~tg/ml cold  methionine. 
The  cell  extracts  were  sub- 
jected to SDS-PAGE and  the 
individual  E1 forms, EI~, Eli, 
and  El,,,  were  excised  from 
the gel.  The gel  pieces  were 
then solubilized in acidic H202, 
b  and counted. (a) Comparison 
of the relative amounts  of Elo 
(e),  Eli (A), and  El,,, (m), at 
37,  35,  30,  25,  and  20°C. 
The  total  incorporation  of 
[35S]methionine  into  the  in- 
fected cells from 7 to 10 h after 
infection at 37, 35, 30, 25, and 
20°C  was  5.3, 5.9,  4.7, 3.2, 
and  2.0  ×  107  cpm,  respec- 
tively.  The percent of counts 
in each form was calculated by 
dividing  the counts eluted  from each form by the total number of 
counts in all forms. (b) Quantitation  of the number of E1 molecules 
per cell  at 37 and 31°C. After labeling  cells  from 7 to 8.5 h after 
infection at 37 or 31°C, the counts in each form of El were quanti- 
tated. The number of E1 molecules  in each form was calculated as- 
suming that each  E1  molecule contains  8 mol of methionine. 
incubation  at  31°C,  the  syncitia  also  failed  to  enlarge 
significantly, The viral envelope glycoprotein E2 is responsi- 
ble  for  viral-induced  cell  fusion  (Sturman  and  Holmes, 
1985) and we attribute the lack of growth of the syncytia to 
the failure in the transport of virions out of the cells.  There 
may  also  be,  at  31°C,  a  reduction  in  the  transport  to  the 
plasma membrane of E2 as a membrane glycoprotein, inde- 
pendent of the transport of virions,  but this  was not inves- 
tigated. This inhibition of the enlargement of the syncytia was 
reversible; they expanded rapidly within 2-3 h after a return 
to 37°C  (data not shown). 
IntraceUular Localization of Viral Budding 
Budding  of progeny  virions,  which  occurs  at  membranes 
with a high concentration of the viral El  spike glycoprotein, 
was first detected in thin sections under the electron micro- 
scope between 6 and 7 h after infection. At these early times, 
the first and only site of budding was a smooth membraned 
compartment with a  complex and irregular vesiculotubular 
morphology (Fig.  8).  This compartment,  which we refer to 
here  as  the budding  compartment,  was always closely as- 
sociated  with  cisternae  of the  rough  ER,  including  transi- 
tional elements.  Usually,  but not always,  the budding com- 
partment  was  also juxtaposed  to the  cis  side  of the  Golgi 
stack (see Fig.  11). Since the membrane of the budding com- 
partment  is smooth it cannot be the site of synthesis of E1 
or  its  insertion  into  membranes.  Furthermore,  we  have 
reported previously that the budding compartment does not 
contain a cytochemical marker of the rough ER (Tooze et al., 
1984).  We conclude that the initial  site of accumulation of 
E1  to  levels  that  support  budding  is  a  distinct  smooth- 
The Journal of Cell Biology, Volume  106,  1988  1480 Figure 7. Indirect immunofluorescence of infected sac(-) cells labeled with a mAb specific for El. Infected sac(-) were incubated at 37°C 
until (a) 7 h after infection, (b) 12 h after infection, or (c) incubated until 7 h after infection at 37°C and then shifted to 31°C until 12 h 
after infection, fixed, and labeled. Bar, 10 Ixm. 
membraned compartment usually found between transitional 
elements of the rough ER and usually lies between them and 
the Golgi complex. 
Examination of single and serial sections showed that this 
distinct compartment also exists in uninfected cells (Fig.9), 
where it is also invariably associated with transitional ele- 
ments of the rough  ER and  Golgi stacks.  Comparison of 
Figs.  8 and 9 shows that the budding compartment is more 
dilated in infected than in uninfected cells. In part, no doubt, 
this is a result of the budding of virions, each ~1,000/~ in 
diam, into this compartment in the infected cells. Although 
we have not made extensive morphometric analyses of the 
budding compartment, it is clear from examination of single 
and  serial  sections  that  its  volume  and  surface  area  are 
smaller than those of either the Golgi complex or the rough 
ER. 
Beginning between 8 and 9 h after infection at 37°C, the 
rough ER becomes a site of budding of virions and progres- 
sively more viruses bud and accumulate in this compartment 
(Tooze et al., 1984,  1985). Virions can also be seen increas- 
ingly in the rims of Golgi cisternae and in post-Golgi vesicles 
transporting the virus to the cell surface. The Golgi cisternae 
become distended and eventually vesiculate; by 12 h after in- 
fection cell lysis starts (Tooze et al.,  1984; and unpublished 
observations). 
Morphological Changes Induced by a Shift to 31°C 
By contrast, when cultures are shifted at 5-7 h after infection 
from 37 to 31°C, the infected cells survive for at least a fur- 
ther 18 h. At 24 h after infection, their Golgi stacks have re- 
tained their morphological integrity.  Few virions are seen 
within the Golgi cisternae or in post-Golgi transport vesicles 
(Fig.  10), and very few are seen outside the cells associated 
with the plasma membrane. On the other hand, the rough ER 
contains massive accumulations of virions (Fig.  10). These 
morphological observations indicate that there is little trans- 
port of virions into the Golgi stacks and beyond at 31°C. We 
believe that it is this block to virion transport that prevents 
the  disruption  of the  Golgi  stacks,  which  is  one  of the 
cytopathic effects of MHV-A59 infection at 37°C and is also 
observed in cells infected at 37°C with Uukuniemi virus, a 
bunyavirus that buds into intracellular membranes (Gahm- 
berg et al.,  1986). 
Localization of  E1 by Immunoelectron Microscopy 
Using an immunoperoxidase labeling technique and a mAb 
against an amino-terminal epitope of E1 (Tooze and Stanley, 
1986), we determined at the level of resolution of the electron 
microscope  which  membranes  contained  E1  at  different 
times after infection at the two temperatures. At 5-7 h after 
infection at 37°C, the rough ER was not labeled but the bud- 
ding compartment was labeled as expected from indirect im- 
munofluorescence  microscopy. There was also distinct label- 
ing  of all  the  stacked  cisternal  membranes  of the  Golgi 
complex (Fig. 11). The reaction product was found on the lu- 
menal side of these compartments (Fig.  11) consistent with 
the fact that the mAb recognizes an amino-terminal epitope 
of El. Continued incubation at 37°C increased the number 
of labeled compartments to include the rough ER (Tooze et 
al.  1985). 
The labeling of Golgi cisternae at 5-7 h after infection indi- 
cates that some E1 reaches the cisternal membranes as an in- 
tegral membrane protein. However, the absence of budding 
of virions directly into the Golgi cisternae at these early 
times after infection (Tooze et al., 1984; Figs. 9 and 11) indi- 
cates that the amount of E1 in these membranes is below the 
threshold concentration necessary for budding but clearly is 
not below the threshold of detection by the immunoperoxi- 
dase technique which involves enzymatic amplification. 
After a shift from 37 to 31°C at times between 5 and 7 h 
after infection, with 3-5 h  further incubation at the lower 
temperature,  the  labeling  pattern  of  E1  using  the  im- 
Tooze et al.  GalNAc Addition  to MHV-A59 E1  Glycoprotein  1481 Figure  8.  A gallery of micrographs  of the budding compartment in sac(-) cells at 6-7 h after  infection with MHV-A59. The smooth- 
membraned budding compartment with progeny virions and budding figures (arrows)  is closely associated with cisternae of the rough ER, 
including  transitional  elements (te in B), which at this early stage of infection are not a site of virus budding. These examples were selected 
to show budding compartments not juxtaposed to Golgi stacks and therefore are comparable to the budding compartment in an uninfected 
cell shown in Fig. 9. (Budding compartments close to Golgi stacks are shown in Fig.  11.) Note the irregular form of this compartment 
and its distension by the accumulating virions. Frequently parts of the cytoplasmic face of the budding compartment have a "bristle" coat 
and appear to be sites of fusion of small vesicles (arrowheads in A, B, D, and E). This coat differs in morphology from the coats of typical 
coated vesicles (open arrows in A and C). Orci et al.  (1986) have shown by immunocytochemistry  that coats of this type associated with 
Golgi membranes lack clathrin. Bars, 0.25  vtm. 
The Journal of Cell Biology, Volume 106, 1988  1482 Figure 9. Serial sections through a budding compartment in an uninfected sac(-) cell. In uninfected cells this compartment (arrowheads) 
is found closely associated with transitional element regions of the rough ER (arrows). Often the budding compartment occurs between 
transitional elements and Golgi stacks but sometimes,  as this figure shows, it is not adjacent to a Golgi stack.  In this situation, because 
of the absence of smooth cis-Golgi membranes, it is easier to trace the budding compartment through  serial sections.  Note the complex 
irregular morphology of the budding compartment and the absence of ribosomes from its membrane. The micrographs  shown are of nine 
sections (SI-$5, $7, and $I0-S12) from a continuous ribbon of 13 sections, each ,~50-60 nm thick. In this example, therefore, the budding 
compartment extended through a depth of ,,,650  nm. All micrographs  are at the same magnification.  Bar, 0.25  lam. 
Tooze et al. GalNAc Addition to MHV-A59 E1 Glycoprotein  1483 Figure 10. Micrographs of sac(-) cells shifted at 7 h after infection with MHV-A59  from 37 to 31°C, and incubated until 24 h after infection 
before fixation. (A) This shows the accumulation of virions in the rough ER (arrowheads)  and smooth perinuclear vesicles (arrows).  The 
Golgi stack (open arrow) retains its morphology even at 24 h after infection; note there are no virions in the Golgi cisternae. (B) During 
incubation at 31°C, the cisternae of the rough ER (arrows)  become filled with virions but there are extremely few virions released from 
the cells (arrowheads). For comparison, the inset is a micrograph of part of the surface of a cell at 14 h after infection at 37°C showing - 
how numerous released progeny virions (arrowheads)  often remain close to the plasma membrane of the cell from which they emerged. 
Bars, 0.5 I.tm. 
munoperoxidase technique was very similar to that seen at 
7 h after infection at 37°C. Reaction product was seen in the 
budding compartment and some in the Golgi cisternae (data 
not shown). 
Discussion 
There are at least two posttranslational modifications which 
result in a change in the molecular mass of coronavirus El. 
The first involves addition of GalNAc ~10 min after synthe- 
Sis; the molecular mass increase of 1 kD would correspond 
to the addition of three GaINAC molecules. The sequence of 
E1 (Armstrong et al.,  1984) shows that there are four poten- 
tial  glycosylation sites  for O-linked oligosaccharides at the 
amino  terminus  of the  protein  (NH2-Ser-Ser-Thr-Thr)  of 
which a maximum of three are used (Niemann et al.,  1984). 
About 10 min later, Gal and NANA are added to give a vari- 
ety of mature E1 forms which can be explained by variation 
in the number of GalNAc residues that are modified and by 
the heterogeneity of the mature sialylated oligosaccharides. 
The addition of Gal and NANA probably occurs in the 
trans-Golgi  complex,  because the  necessary enzymes are 
found there (Carlson et al., 1973; Sadler et al., 1979; Rearick 
et al.,  1979; Elhammer and Kornfeld, 1984) and drugs which 
inhibit transport into and through the Golgi complex (Quinn 
et al.,  1983; Tartakoff et al.,  1983) inhibit formation of the 
mature oligosaccharide structure.  We have found that both 
monensin and  CCCP inhibit  the  glycosylation of E1  in  a 
manner essentially identical to the inhibition at 31°C (Tooze, 
1987). Such results  must, however, be interpreted with some 
caution because with these drugs it is often impossible to dis- 
tinguish between inhibition of transport and direct inhibition 
of the enzymes which add the sugars. 
The pathway taken by newly synthesized E1 is complicated 
by the intracellular budding of the virus. At its simplest, one 
can envisage that E1 moves to the budding compartment, nu- 
cleocapsids bind and bud,  and E1  then moves through the 
secretory pathway  as part of the maturing virion. However, 
immunoperoxidase  labeling  shows  clearly  that  E1  in  the 
Golgi complex is not only present in virions but also in every 
cisternal membrane (see Fig. 11). The amount of E1 in Golgi 
membranes cannot be estimated because of the catalytic na- 
ture of the peroxidase technique but, until very late in the vi- 
ral  infection,  it must be lower than that needed to support 
The Journal of Cell Biology, Volume  106,  1988  1484 Figure 11. (A) Immunoperoxidase  labeling of E1 in a sac(-) cell at 6 h after infection with MHV-A59. Heavily labeled budding figures 
(open arrows) can be seen in the budding compartment close to a Golgi stack. All cisternae of the Golgi stack are labeled (arrows). However, 
at this stage of infection the cisternae of  the rough ER (arrowheads) are not labeled above background. (B) The Golgi region of a convention- 
ally fixed and embedded cell at 6 h, 20 min after infection for comparison  with A. Note the budding figures and budded virions in the 
budding compartment  (open arrows) which lies between the Golgi stack (arrows) and the rough ER (arrowhead).  At this early stage of 
infection the budding of virions  is confined to the budding compartment.  Bars, 0.25  ~tm. 
budding of the virus. This accumulation of E1  in the Golgi 
membranes  during  infection  may  represent  a  dead  end 
caused by "leakage" of E1 from the budding compartment if 
the nucleocapsids are unable to trap all of the E1 in budding 
virions. This idea is supported by the finding that E1  is not 
transported beyond the Golgi stack in cellular membranes 
(Tooze and Stanley, 1986; Tooze et al.,  1987). Alternatively, 
cisternal E1 may represent a genuine part of the maturation 
pathway. El may have to move through Golgi cisternae and 
then back again to the budding compartment before it can 
participate  in  the  budding  reaction.  This  seems  very un- 
likely, however, because all attempts to show movement of 
other ER proteins to the  Golgi stack and back again have 
failed (Yamamoto et al.,  1985;  Brands et al.,  1985).  It is, 
therefore, more reasonable to assume that E1  is transported 
from the membrane of the ER to the budding compartment 
where it reaches a concentration sufficient to allow budding 
for the first time. Thereafter, incorporated into the envelope 
of progeny virions,  it  moves through  the  Golgi stack and 
thence to the cell surface with only a small amount leaking 
to the Golgi stack independent of the virions. As the infection 
progresses the amount of El being synthesized increases (our 
unpublished data) and at the same time budding of progeny 
virions directly into the lumen of the rough ER begins and 
increases. We interpret this to indicate that the rate of inser- 
tion of E1 into the rough ER membrane beings to exceed the 
rate  of its  transport  out  of the  ER  to  the  budding  com- 
partment. 
Reducing the temperature to 31°C profoundly inhibits the 
release of virions into the medium.  All the morphological 
evidence suggests that at 31°C it is the entry of virions into 
the Golgi complex that is inhibited; as a result, few virions 
are seen in the Golgi cisternae or in the post Golgi transport 
vesicles and the Golgi stack maintains its normal morphol- 
ogy. The inhibition of virion transport is accompanied by an 
inhibition of terminal glycosylation. This would be expected 
if (a)  terminal  glycosylation  occurred  in  the  trans-Golgi 
complex and, (b) if the E1 is delivered there normally incor- 
porated in the envelopes of progeny virions rather than as an 
integral protein of cellular membranes. But at 31°C, addition 
of GalNAc still occurs to an unchanged extent suggesting that 
this sugar is added in or just before the budding compartment. 
Interestingly, the amount of E1  containing GalNAc (El0 
does not change when the temperature is reduced.  The de- 
Tooze et al.  GaINAc Addition  to MHV-A59 E1  Glycoprotein  1485 crease in Elm is accompanied only by an increase in El°. 
This correlates with the increase in budding into the rough 
ER and further argues that GalNac is not added in the rough 
ER but in the budding compartment. If GalNAc was added 
either cotranslationally or while the E1 resided in the rough 
ER membrane, an increase in the amount of the Eli form 
would be expected both at 37 and 31°C as the concentration 
of E1 reaches levels that not only support budding into this 
compartment but also can readily be detected by immunocy- 
tochemistry  (Tooze et  al.,  1985).  However,  the  constant 
amount  of E1  containing  GalNAc  (Eli)  implies  that  the 
compartment in which the sugar is added has a limited ca- 
pacity and is smaller than the rough ER. Morphological evi- 
dence indicates that the budding compartment fulfills these 
criteria. 
The budding compartment is not a product of infection be- 
cause it is found in uninfected sac(-) cells and our prelimi- 
nary observations of serial sections of rat exocrine pancreatic 
cells and murine AtT20 cells shows that it is not peculiar to 
sac(-) cells. In all three cell types, the budding compart- 
ment is found frequently in close association with patches of 
rough ER differentiated into transitional elements in regions 
juxtaposed to the cis side of the Golgi apparatus. However, 
the budding compartment and transitional elements of the 
rough ER in sac(-) cells are not restricted to this region; 
they also occur associated with patches of rough ER remote 
from the Golgi apparatus. The existence of peripheral transi- 
tional  elements  in  pancreatic  cells has  long  been known 
(Jamieson and Palade, 1967). Our observations, together with 
those of Saraste and Kuismanen (1984), Tartakoff  (1986), and 
Merisko et al. (1986) indicate that the structure of the transi- 
tional element-transitional vesicle region of the cell is con- 
siderably more complex than hitherto appreciated. 
Fig.  12 summarizes our interpretation of the results de- 
scribed above which  suggest that GalNAc is added in the 
budding compartment. This is not to say that the enzyme, 
N-acetyl-galactosaminyltransferase, is  found exclusively in 
this  compartment,  although  available  fractionation  data 
shows that it is restricted to smooth membranes (Kim et al., 
1971; Ko and Raghupathy, 1972; Hanover et al.,  1980, 1982; 
Elhammer and Kornfeld,  1984).  One must remember that 
the position of  an enzyme can only be inferred from the posi- 
tion of the  substrate and product subject to certain strict 
criteria.  Obviously, the  enzyme cannot be located in  the 
pathway after the point at which the substrate acquires the 
sugar, but it can exist at any site up to the point at which the 
substrate appears to be modified. This is because the substate 
may have to assume a particular conformation before it can 
be acted upon by the enzyme. The N-acetyl-galactosaminyl- 
transferase could be present earlier in the pathway than the 
budding compartment but the E1 may not be a substrate until 
it  reaches  the  budding  compartment.  Alternatively,  the 
means of detecting the modification may depend on the sub- 
strate conformation. The presence of  protein-bound GalNAc 
in the cis Golgi as detected by lectin labeling (Roth,  1984) 
may reflect addition of the sugar in this compartment or in 
some  prior  compartment  in  which  the  protein-bound 
oligosaccharide is inaccessible to the lectin. These possibili- 
ties are not normally considered but they could explain the 
large and otherwise irreconcilable discrepancies in the loca- 
tion that has been assigned to N-acetyl-galactosaminyltrans- 
ferase (Strous, 1979; Niemann et al., 1982; Cummings et al., 
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Figure 12. Schematic illustrating the first site of budding of MHV- 
A59 into a smooth membrane compartment between the transi- 
tional elements of  the ER and the Golgi stack. Reduced temperature 
blocks entry of the virions into the Golgi stack and prevents El ac- 
quiring galactose and sialic acid but not GalNAc. This sugar is 
probably added in the budding compartment which is of  limited size 
and distinct from both the ER and Golgi apparatus. 
1983; Johnson and Spear, 1983). These differences will only 
be resolved by locating the enzyme itself using an immuno- 
cytochemical technique. 
The transport to the plasma membrane of the envelope gly- 
coproteins of the  influenza virus,  SFV,  and  VSV  can be 
slowed in the trans-most Golgi compartment by reducing the 
incubation temperature from 37 to 20°C (Matlin and Simons, 
1983;  Saraste and Kuismanen,  1984;  Fuller et al.,  1985). 
Blocking the transport of these proteins from the rough ER 
to the Golgi stacks requires a further reduction in tempera- 
ture to  16°C (Saraste and Kuismanen,  1984).  By contrast, 
lowering the incubation temperature by only 6°C, from 37 to 
31°C, results in at least a 1,000-fold reduction in the release 
of MHV-A59 virions and concommitantly blocks the com- 
pletion of the O-glycosylation of the E1 viral envelope glyco- 
protein, as we have shown here. Why the transport of MHV- 
A59 particles from the budding compartment to the Golgi 
apparatus and thence out of the cell is so very much more 
cold sensitive than the transport out of the rough ER of the 
envelope glycoproteins of VSV and SFV remains to be ex- 
plained. Possibly the difference stems from the fact that in 
one case it is whole virions which are being transported and, 
in the other, viral glycoproteins inserted into cellular mem- 
branes. 
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